Table 2.
ID | Amblyopic visual acuity (logMAR) | Stereosensitivity (arc s-1) | RDK suppression (% contrast) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pre | Post-5d | Post-10d | Post-2w | Post-3 m | Pre | Post-5d | Post-10d | Post-2w | Post-3m | Pre | Post-5d | Post-10d | |
G1-1 | 0.70 | 0.48 | 0.48 | 0.45 | 0.40 | 0 | 0.00125 | 0.00125 | 0.00125 | 0.00125 | 0 | 28 | 22 |
G1-2 | 1.00 | 0.57 | 0.55 | 0.55 | 0.52 | 0 | 0 | 0 | 0 | 0 | 10 | 29 | 38 |
G1-3 | 0.22 | 0.15 | 0.10 | 0.10 | 0.08 | 0.00125 | 0.00500 | 0.01000 | 0.00500 | 0.00250 | 34 | 50 | 78 |
G1-4 | 0.40 | 0.21 | 0.21 | 0.22 | 0.22 | 0 | 0 | 0 | 0 | 0 | 2 | 15 | 20 |
G1-5 | 0.16 | 0.12 | 0.08 | – | – | 0.00125 | 0.00500 | 0.00500 | – | – | 32 | 65 | 77 |
G1-6 | 0.73 | 0.57 | 0.30 | – | – | 0 | 0.00125 | 0.00125 | – | – | 28 | 36 | 40 |
G1-7 | 0.42 | 0.33 | 0.18 | – | – | 0 | 0.00125 | 0.00250 | – | – | 45 | 100 | 100 |
G1-8 | 1.00 | 0.70 | 0.42 | – | – | 0 | 0 | 0 | – | – | 0 | 13 | 14 |
G2-1 | 0.15 | 0.05 | 0.03 | 0.00 | −0.05 | 0.00125 | 0.00500 | 0.01000 | 0.01000 | 0.01000 | 2 | 33 | 41 |
G2-2 | 1.00 | 0.57 | 0.55 | 0.45 | 0.42 | 0 | 0 | 0.00125 | 0.00125 | 0.00250 | 19 | 100 | 100 |
G2-3 | 1.00 | 0.60 | 0.55 | 0.52 | 0.60 | 0 | 0 | 0.00125 | 0.00250 | 0.00250 | 2 | 15 | 20 |
G2-4 | 0.57 | 0.35 | 0.27 | 0.30 | 0.38 | 0 | 0 | 0.00125 | 0.00125 | 0.00125 | 26 | 37 | 69 |
G2-5 | 0.55 | 0.33 | 0.17 | – | – | 0 | 0 | 0.00250 | – | – | 25 | 37 | 54 |
G2-6 | 0.38 | 0.25 | 0.15 | – | – | 0.00125 | 0.00250 | 0.00500 | – | – | 35 | 48 | 51 |
G2-7 | 0.70 | 0.42 | 0.25 | – | – | 0 | 0 | 0.00125 | – | – | 24 | 29 | 40 |
G2-8 | 1.00 | 0.70 | 0.48 | – | – | 0 | 0 | 0 | – | – | 0 | 16 | 19 |
Measurements of visual acuity, stereosensitivity (s arc-1) and suppression for individual participants. Suppression was measured as the Weber contrast that could be tolerated in the fellow eye when the amblyopic eye was presented with a stimulus at 100 % contrast and larger values indicate weaker suppression (less contrast difference between the eyes was required). Measurements are provided prior to treatment (Pre) after 5 days (post-5d), after 10 days (post-10d), 2 weeks after the final treatment session (post-2w) and 3 months after the final treatment session (post-3 m)
G1 participants who received anodal-transcranial direct current stimulation (tDCS) first (group 1), G2 patients who received sham-tDCS first (group 2); RDK random dot kinematogram